{"entity":{"type":"insider","cik":"0001576318","url":"/insider/0001576318","json_url":"/insider/0001576318.json","name":"Zhao Hong","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":11,"n_filings":7,"first":"2014-05-16","last":"2017-08-16","span_basis":"filed_date"},"name_variants":[{"name":"Zhao Hong","source":"filing","n_filings":7,"first_seen":"2014-05-16","last_seen":"2017-08-16"}],"transactions":[{"id":5195427,"accession":"0000880771-17-000130","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000880771-17-000130","line_url":"/filing/0000880771-17-000130#line-2","is_derivative":false,"issuer_cik":"0000880771","issuer_name":"SCICLONE PHARMACEUTICALS INC","issuer_ticker":"SCLN","issuer_name_source":null,"issuer_url":"/issuer/0000880771","owner_cik":"0001576318","owner_name":"Zhao Hong","owner_url":"/insider/0001576318","role":"Officer (CEO, China Operations)","officer_title":"CEO, China Operations","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":30000.0,"shares_display":"30,000","price_per_share":11.0,"price_display":"11.00","price_state":"stated","total_value":330000.0,"total_display":"330,000.00","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-08-16","filed_date":"2017-08-16","scope":"insider"},{"id":4836200,"accession":"0000880771-17-000106","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0000880771-17-000106","line_url":"/filing/0000880771-17-000106#line-6","is_derivative":false,"issuer_cik":"0000880771","issuer_name":"SCICLONE PHARMACEUTICALS INC","issuer_ticker":"SCLN","issuer_name_source":null,"issuer_url":"/issuer/0000880771","owner_cik":"0001576318","owner_name":"Zhao Hong","owner_url":"/insider/0001576318","role":"Officer (CEO, China Operations)","officer_title":"CEO, China Operations","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25000.0,"shares_display":"25,000","price_per_share":10.75,"price_display":"10.75","price_state":"stated","total_value":268750.0,"total_display":"268,750.00","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-06-12","filed_date":"2017-06-14","scope":"insider"},{"id":4836197,"accession":"0000880771-17-000106","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0000880771-17-000106","line_url":"/filing/0000880771-17-000106#line-5","is_derivative":false,"issuer_cik":"0000880771","issuer_name":"SCICLONE PHARMACEUTICALS INC","issuer_ticker":"SCLN","issuer_name_source":null,"issuer_url":"/issuer/0000880771","owner_cik":"0001576318","owner_name":"Zhao Hong","owner_url":"/insider/0001576318","role":"Officer (CEO, China Operations)","officer_title":"CEO, China Operations","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12500.0,"shares_display":"12,500","price_per_share":10.75,"price_display":"10.75","price_state":"stated","total_value":134375.0,"total_display":"134,375.00","shares_owned_after":25000.0,"shares_owned_after_display":"25,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-06-12","filed_date":"2017-06-14","scope":"insider"},{"id":4836191,"accession":"0000880771-17-000106","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000880771-17-000106","line_url":"/filing/0000880771-17-000106#line-4","is_derivative":false,"issuer_cik":"0000880771","issuer_name":"SCICLONE PHARMACEUTICALS INC","issuer_ticker":"SCLN","issuer_name_source":null,"issuer_url":"/issuer/0000880771","owner_cik":"0001576318","owner_name":"Zhao Hong","owner_url":"/insider/0001576318","role":"Officer (CEO, China Operations)","officer_title":"CEO, China Operations","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3000.0,"shares_display":"3,000","price_per_share":10.75,"price_display":"10.75","price_state":"stated","total_value":32250.0,"total_display":"32,250.00","shares_owned_after":37500.0,"shares_owned_after_display":"37,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-06-12","filed_date":"2017-06-14","scope":"insider"},{"id":4432999,"accession":"0000880771-17-000054","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000880771-17-000054","line_url":"/filing/0000880771-17-000054#line-2","is_derivative":false,"issuer_cik":"0000880771","issuer_name":"SCICLONE PHARMACEUTICALS INC","issuer_ticker":"SCLN","issuer_name_source":null,"issuer_url":"/issuer/0000880771","owner_cik":"0001576318","owner_name":"Zhao Hong","owner_url":"/insider/0001576318","role":"Officer (CEO, China Operations)","officer_title":"CEO, China Operations","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3000.0,"shares_display":"3,000","price_per_share":9.6,"price_display":"9.60","price_state":"stated","total_value":28800.0,"total_display":"28,800.00","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-03-15","filed_date":"2017-03-17","scope":"insider"},{"id":3027542,"accession":"0000880771-16-000183","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0000880771-16-000183","line_url":"/filing/0000880771-16-000183#line-6","is_derivative":false,"issuer_cik":"0000880771","issuer_name":"SCICLONE PHARMACEUTICALS INC","issuer_ticker":"SCLN","issuer_name_source":null,"issuer_url":"/issuer/0000880771","owner_cik":"0001576318","owner_name":"Zhao Hong","owner_url":"/insider/0001576318","role":"Officer (CEO, China Operations)","officer_title":"CEO, China Operations","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25000.0,"shares_display":"25,000","price_per_share":10.41,"price_display":"10.41","price_state":"stated","total_value":260250.0,"total_display":"260,250.00","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-08-12","filed_date":"2016-08-16","scope":"insider"},{"id":3027540,"accession":"0000880771-16-000183","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0000880771-16-000183","line_url":"/filing/0000880771-16-000183#line-5","is_derivative":false,"issuer_cik":"0000880771","issuer_name":"SCICLONE PHARMACEUTICALS INC","issuer_ticker":"SCLN","issuer_name_source":null,"issuer_url":"/issuer/0000880771","owner_cik":"0001576318","owner_name":"Zhao Hong","owner_url":"/insider/0001576318","role":"Officer (CEO, China Operations)","officer_title":"CEO, China Operations","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12500.0,"shares_display":"12,500","price_per_share":10.41,"price_display":"10.41","price_state":"stated","total_value":130125.0,"total_display":"130,125.00","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-08-12","filed_date":"2016-08-16","scope":"insider"},{"id":3027537,"accession":"0000880771-16-000183","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000880771-16-000183","line_url":"/filing/0000880771-16-000183#line-4","is_derivative":false,"issuer_cik":"0000880771","issuer_name":"SCICLONE PHARMACEUTICALS INC","issuer_ticker":"SCLN","issuer_name_source":null,"issuer_url":"/issuer/0000880771","owner_cik":"0001576318","owner_name":"Zhao Hong","owner_url":"/insider/0001576318","role":"Officer (CEO, China Operations)","officer_title":"CEO, China Operations","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3000.0,"shares_display":"3,000","price_per_share":10.41,"price_display":"10.41","price_state":"stated","total_value":31230.0,"total_display":"31,230.00","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-08-12","filed_date":"2016-08-16","scope":"insider"},{"id":8511048,"accession":"0001576318-15-000002","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001576318-15-000002","line_url":"/filing/0001576318-15-000002#line-2","is_derivative":false,"issuer_cik":"0000880771","issuer_name":"SCICLONE PHARMACEUTICALS INC","issuer_ticker":"SCLN","issuer_name_source":null,"issuer_url":"/issuer/0000880771","owner_cik":"0001576318","owner_name":"Zhao Hong","owner_url":"/insider/0001576318","role":"Officer (CEO, China Operations)","officer_title":"CEO, China Operations","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":9.2338,"price_display":"9.23","price_state":"stated","total_value":92338.0,"total_display":"92,338.00","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-06-08","filed_date":"2015-06-09","scope":"insider"},{"id":8737534,"accession":"0000880771-15-000070","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000880771-15-000070","line_url":"/filing/0000880771-15-000070#line-2","is_derivative":false,"issuer_cik":"0000880771","issuer_name":"SCICLONE PHARMACEUTICALS INC","issuer_ticker":"SCLN","issuer_name_source":null,"issuer_url":"/issuer/0000880771","owner_cik":"0001576318","owner_name":"Zhao Hong","owner_url":"/insider/0001576318","role":"Officer (CEO, China Operations)","officer_title":"CEO, China Operations","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12500.0,"shares_display":"12,500","price_per_share":9.07,"price_display":"9.07","price_state":"stated","total_value":113375.0,"total_display":"113,375.00","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-05-14","filed_date":"2015-05-18","scope":"insider"},{"id":6468166,"accession":"0001576318-14-000004","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001576318-14-000004","line_url":"/filing/0001576318-14-000004#line-2","is_derivative":false,"issuer_cik":"0000880771","issuer_name":"SCICLONE PHARMACEUTICALS INC","issuer_ticker":"SCLN","issuer_name_source":null,"issuer_url":"/issuer/0000880771","owner_cik":"0001576318","owner_name":"Zhao Hong","owner_url":"/insider/0001576318","role":"Officer (CEO, China Operations)","officer_title":"CEO, China Operations","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12500.0,"shares_display":"12,500","price_per_share":4.75,"price_display":"4.75","price_state":"stated","total_value":59375.0,"total_display":"59,375.00","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-05-16","filed_date":"2014-05-16","scope":"insider"}],"next_cursor":null,"ledger_fault":false,"count":{"value":11,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":11,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":11},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0000880771","name":"SCICLONE PHARMACEUTICALS INC","url":"/issuer/0000880771","role":"Officer (CEO, China Operations)","n_filings":7,"first_seen":"2014-05-16","last_seen":"2017-08-16"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001576318","retrieved_at":"2026-08-21T05:45:42+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-20","last_ingest":"2026-08-21T05:23:33.898496+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}